Literature DB >> 8097861

Etonitazene: an opioid selective for the mu receptor types.

M S Moolten1, J B Fishman, J C Chen, K R Carlson.   

Abstract

Specific radioligand binding protocols were utilized to compare the affinity of morphine and the high-potency opioid etonitazene at mu 1, mu 2, delta, kappa 1 and sigma receptors. Both etonitazene and morphine displayed a mu 1-selective binding profile; however, etonitazene had a 2500-fold higher affinity at this receptor type. The latter result is consistent with the relative potencies or morphine and etonitazene in various behavioral tests.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097861     DOI: 10.1016/0024-3205(93)90118-m

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Development of tolerance and sensitization to different opioid agonists in rats.

Authors:  Gisela Grecksch; Katharina Bartzsch; Antje Widera; Axel Becker; Volker Höllt; Thomas Koch
Journal:  Psychopharmacology (Berl)       Date:  2006-03-30       Impact factor: 4.530

Review 2.  Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.

Authors:  Amanda L A Mohr; Barry K Logan; Melissa F Fogarty; Alex J Krotulski; Donna M Papsun; Sherri L Kacinko; Marilyn A Huestis; Jeri D Ropero-Miller
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

3.  Intravenous morphine self-administration by rats with low versus high saccharin preferences.

Authors:  B A Gosnell; K E Lane; S M Bell; D D Krahn
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

4.  Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine.

Authors:  Cindy Achat-Mendes; Glenn R Valdez; Donna M Platt; James K Rowlett; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2009-02-19       Impact factor: 4.530

5.  Exploring the effectiveness of novel benzimidazoles as CB2 ligands: synthesis, biological evaluation, molecular docking studies and ADMET prediction.

Authors:  Michele Tonelli; Elena Cichero; Alì Mokhtar Mahmoud; Alessandro Rabbito; Bruno Tasso; Paola Fossa; Alessia Ligresti
Journal:  Medchemcomm       Date:  2018-10-10       Impact factor: 3.597

6.  Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands.

Authors:  Zhijun Wu; Victor J Hruby
Journal:  ACS Omega       Date:  2019-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.